Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide

N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide

N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide structure

N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide 

structure
  • CAS No:

    850879-09-3

  • Formula:

    C23H21N5O3S

  • Chemical Name:

    N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide

  • Synonyms:

    N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide;1-Piperazinecarbothioamide, N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro(3,2-D)pyrimidin-4-yl-;Mp470;AMuvatinib;HPK 56;MP-470(MP 470);AMuvatinib (MP-470);AMuvatinib (MP-470, HPK 56)

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively.IC50 Value: 10 nM(c-KitD816H); 40 nM(PDGFRαV561D); 81 nM(Flt3D835Y) [1]Target: c-Kit; PDGFRα; FLT3in vitro: The hydrochloride salt of MP-470 also inhibits several mutants of c-Kit, including c-KitD816V, c-KitD816H, c-KitV560G, and c-KitV654A, as well as a Flt3 mutant (Flt3D835Y) and two PDGFRα mutants (PDGFRαV561D and PDGFRαD842V), with IC50 of 10 nM to

N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide Basic Attributes

447.51

447.136505

Characteristics

108

3.5

1.4±0.1 g/cm3

649.5±65.0°C at 760 mmHg

346.6±34.3 °C

1.739

N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide Use and Manufacturing

Methods of Manufacturing

4-Benzo[4, 5]furo[3, 2-d]pyrimidin-4-yl-piperazine-1-carbothioic acid (benzof1, 31dioxol-5-ylmethvl)-amide (3) To a solution of 4-piperazinobenzofurano [3, 2-d] pyrimidine (200 mg, 0.79 mmol) and pyridine (0.5 mL, 7.9 mmol) in dichloromethane (20 mL) was added a solution of product 1c in dichloromethane (20mL) and this was stirred overnight. Methanol was added to quench excess thiophosgene, and the residue after removal of solvent was purified by silica gel column chromatography eluting with 5percent methanol/dichloromethane and further recrystallized from dichloromethane/hexane to give 150 mg (37percent). HNMR (CDCl3, 300MHZ) a 4.09 (s, 4H), 4.27 (s, 4H), 4.82 (d, J = 4.7Hz, 2H), 5.99 (s, 2H), 6.77-6. 79 (m, 1 H), 6.80-6. 83 (m, 1H), 6.89 (s, 1 H), 7.47-7. 52 (m, 1 H), 7.61-7. 65 (m, 1 H), 7.66-7. 70 (m, 1 H), 8.33 (d, J = 7. 0Hz, 1 H). FAB HRMS [M+H] + calcd for C23H21N503S : 447.1365 ; found 448. 1443. Combustion Analysis: C23H21N5O3S Requires C 61.73percent, H 4.73percent, N 15.65percent, O 10.73percent, S 7.17percent ; Found C 61. 95percent, H 4.99percent, N 15.93percent, 0 11. 13percent, S 7. 55percent.

Uses

MP-470 (Amuvatinib) is a potent and multi-targeted inhibitor of c-KitD816H, PDGFαV561D and Flt3D835Y with IC50 of 10 nM, 40 nM and 81 nM, respectively.

Recommended Suppliers of N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.